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Abstract
Background: Experience during early postnatal development plays an important role in the refinement of specific neural
connections in the brain. In the mammalian visual system, altered visual experiences induce plastic adaptation of visual
cortical responses and guide rearrangements of afferent axons from the lateral geniculate nucleus. Previous studies using
visual deprivation demonstrated that the afferents serving an open eye significantly retract when cortical neurons are
pharmacologically inhibited by applying a c-aminobutyric acid type A receptor agonist, muscimol, whereas those serving a
deprived eye are rescued from retraction, suggesting that presynaptic activity can lead to the retraction of geniculocortical
axons in the absence of postsynaptic activity. Because muscimol application suppresses the spike activity of cortical neurons
leaving transmitter release intact at geniculocortical synapses, local synaptic interaction may underlie the retraction of
active axons in the inhibited cortex.
Method and Findings: New studies reported here determined whether experience-driven axon retraction can occur in the
visual cortex inactivated by blocking synaptic inputs. We inactivated the primary visual cortex of kittens by suppressing
synaptic transmission with cortical injections of botulinum neurotoxin type E, which cleaves a synaptic protein, SNAP-25,
and blocks transmitter release, and examined the geniculocortical axon morphology in the animals with normal vision and
those deprived of vision binocularly. We found that afferent axons in the animals with normal vision showed a significant
retraction in the inactivated cortex, as similarly observed in the muscimol-treated cortex, whereas the axons in the
binocularly deprived animals were preserved.
Conclusions: Therefore, the experience-driven axon retraction in the inactivated cortex can proceed in the absence of
synaptic transmission. These results suggest that presynaptic mechanisms play an important role in the experience-driven
refinement of geniculocortical axons.
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Introduction
Experience during early postnatal development plays an
important role in the development of brain function and the
refinement of specific neural connections. In the mammalian
visual system, monocular visual deprivation (MD) in early life
induces a loss of cortical response to a deprived eye together with a
significant retraction of afferent axons from the lateral geniculate
nucleus (LGN) serving the deprived eye (ocular dominance
plasticity) [1–4]. Previous studies showed that activity-dependent
mechanisms should play a crucial role in experience-driven
plasticity. For example, MD does not induce ocular dominance
plasticity when the activity of cortical cells and their inputs from
LGN are both blocked by tetrodotoxin [5]. Moreover, previous
works have demonstrated a role of the activity of cortical cells
themselves in controlling the direction of ocular dominance
plasticity. When cortical cells are selectively inhibited pharmaco-
logically by a c-aminobutyric acid type A (GABAA) receptor
agonist, muscimol, leaving the activity of geniculocortical afferents
intact, the open eye becomes less effective than the deprived eye
[6–8]. Furthermore, active axons serving the open eye selectively
retract and their cortical territory shrink, whereas axons from the
deprived eye remain mostly intact [7,9]. Subsequent experiments
revealed that presynaptic activity in the absence of postsynaptic
activity, which is induced by visually evoked activity in afferent
axons and cortical inhibition, plays an important role in the
retraction of open eye afferents in the inhibited cortex [10].
These findings suggest a crucial role of the activity of presynaptic
axons in the determination of whether the retraction can occur. In
previous experiments, afferent axons might have retracted by a
presynaptic mechanism in response to, for example, depletion of a
possible trophic signal from cortical cells, which was induced by
inhibiting cortical cells. Alternatively, the signal for retraction might
be delivered only to active afferents as a result of a local synaptic
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inhibits cortical neurons but does not prevent synaptic transmission
itself. For example, it was reported that insufficient activation of
cortical neurons can induce the depression of synaptic transmission
[11], which may lead to afferent retraction through a retrograde
message. To determine whether local synaptic interaction underlies
the axon retraction in the inhibited cortex, it would be useful to
examine theeffectof corticalinactivation byblocking synapticinputs
instead of applying a GABAA receptor agonist.
Botulinum neurotoxins are clostridial proteases that enter nerve
terminals and act on the soluble N-ethylmaleimide–sensitive factor
attachment protein receptor (SNARE) proteins. Botulinum
neurotoxin type E (BoNT/E) specifically cleaves synaptosomal-
associated protein-25 kDa (SNAP-25) and blocks transmitter
release [12,13]. Previous experiments demonstrated that BoNT/
E injections can produce a long-term inactivation of the visual
cortex and hippocampus by blocking spontaneous and evoked
neuronal activity [14,15]. Here, we inactivated the primary visual
cortex of kittens by blocking synaptic transmission with cortical
BoNT/E injections and examined the geniculocortical axon
morphology in the animals with normal vision and those deprived
of vision binocularly. We found that the afferent axons in the
animals with normal vision show a significant retraction in the
inactivated cortex, as similarly observed in the muscimol-treated
cortex, whereas the axons in the binocularly deprived (BD)
animals were mostly preserved. Therefore, the experience-driven
axon retraction in the inactivated cortex can proceed in the
absence of synaptic interaction.
Results
Functional effects of BoNT/E injection on visual cortex
We first examined the effect of cortical BoNT/E injection on
SNAP-25 and neuronal activity in the rat visual cortex. To
estimate the duration of BoNT/E effects, we analyzed the time
course of SNAP-25 cleavage after a single BoNT/E injection into
the visual cortex. The visual cortical tissue was harvested on
various days (1 day, 1 week, 2 weeks, and 4 weeks) after the
injection of BoNT/E solution and subjected to western blot
analysis using a monoclonal antibody that recognizes both intact
and BoNT/E-cleaved SNAP-25. SNAP-25 cleavage was clearly
detected 1 day and 1 week after the BoNT/E injection (Fig. 1).
Cleaved SNAP-25 level decreased to undetectable level 2 and
4 weeks after the injection. Therefore, SNAP-25 cleavage in the
visual cortex would persist for at least 1 week following BoNT/E
injection. BoNT/E-injected animals did not show any sign of
systemic intoxication during this time window.
To determine the effect of BoNT/E injection on cortical
activity, we recorded multiunit activity from the visual cortex of
rats 1 week after BoNT/E injection. As shown in Fig. 2A, we did
not observe any spike activity in the visual cortex treated with
BoNT/E, whereas we found vigorous visual responses and
spontaneous activity in the untreated visual cortex contralateral
to the BoNT/E injection site. We further confirmed the blockade
of neuronal activity in the BoNT/E-treated cortex by evaluating
Egr-1 expression (Fig. 2B). The inducible expression of Egr-1 is
commonly used as a marker of neuronal activity [16]. The level of
Egr-1 expression significantly decreased in the BoNT/E-treated
cortex compared with that in the cortex of normal animals
(average6SEM: 43.561.2%, p,0.05, unpaired t-test). Thus,
single BoNT/E treatment could effectively block neuronal activity
in the visual cortex at least for 1 week.
Effects of visual experience on arborization of
geniculocortical axons in BoNT/E-treated cortex
We labeled geniculocortical afferents of 6-week-old kittens by
microinjecting an anterograde tracer, biotinylated dextran amine
(BDA), into lamina A of LGN. Activity of the visual cortex was
suppressed by disrupting synaptic transmission by cortical injection
ofBoNT/E.Agroupof kittens wasdeprived ofvision inbotheyesby
eyelidsuture.After1 week,thecorticalregioninactivatedbyBoNT/
E was delineated physiologically by mapping the activity of cortical
cells.Assimilarlyobservedinrats(Fig.2A),wefoundnospontaneous
or visually evoked activity in the region around the BoNT/E
injection sites. The inactivated area extended up to 10 mm in the
anterior-posterior direction. We further confirmed the cortical
inactivation by Egr-1 immunostaining (Fig. 3). Egr-1-immunoposi-
tive cells were distributed at a high density in the area far from the
injection sites (Figs. 3A and B). In contrast, the density of Egr-1-
immunopositive cells markedly decreased in the area near the
injection sites (Figs. 3A and C). The region of very low Egr-1
immunoreactivity included the entire medial bank and often
extended beyond the sulcus suprasplenialis and the sulcus lateralis.
Cortical arbors of geniculocortical axons in the BoNT/E inactivated
area were labeled well with BDA, as shown in Fig. 3D. We found no
differencein the quality of labeling between the axons inBD animals
and those in animals with normal vision.
In this study, 10 and 9 axonal arbors in the inactivated region of
area 17 were reconstructed from the normal-vision animals (n=5)
Figure 1. Cleavage of SNAP-25 by BoNT/E injection in visual cortex. (A) Representative immunoblots for SNAP-25 in rat visual cortex on
various days after BoNT/E injection. Cleaved SNAP-25 with a lower molecular weight is clearly observed 1 day and 1 week after BoNT/E injection
(upper panel). Norm, normal animals. (B) Quantification of cleaved SNAP-25. Blot densities were normalized to those of GAPDH. Error bars indicate
SEM. *: P,0.05 (n=3–5 each, one-way ANOVA followed by post hoc Scheffe test).
doi:10.1371/journal.pone.0004193.g001
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examples of arbors from each group are shown in Fig. 4. All of the
arbors in this study represent those serving the contralateral eye.
The terminal arborizations of geniculocortical axons in both
normal-vision and BD animals were mainly localized in layer IV.
The arbors in the normal-vision animals showed a marked
reduction in the complexity of terminal arborization compared
with those in BD animals (Figs. 4A and B). In addition, the cortical
area covered by each arbor in the normal-vision animals was
much smaller than that in BD animals, as clearly shown in surface
views of the arbors.
We quantitatively determined the axonal morphology by
measuring two parameters, the total length of axon segments
and the number of branch points of the cortical arbors of
individual geniculocortical axons and compared them with
published results for the arbors in the animals under various
experimental conditions (Fig. 5 and Table 1) [9,10,17]. In the
BoNT/E-treated cortex, the arbors in the normal-vision animals
were significantly shorter and had fewer branch points than those
in the BD animals. Small arbors in the normal-vision animals
should reflect the net shrinkage of arbors rather than the
suppression of development because they were significantly smaller
than those at the start of BoNT/E injection (normal P40 animals).
On the other hand, the arbors in the BoNT/E-treated cortex of
the BD animals were preserved and similar in branching number
to those in the normal animals at the start of BoNT/E injection
(normal P40), although they were somewhat shorter in total
length. Thus, in the cortex inactivated by BoNT/E injection, the
arbors serving the open eye, which carry visual information,
showed a highly significant shrinkage and the shrinkage could be
alleviated by visual deprivation, as observed in the cortex inhibited
by muscimol treatment [9,10].
The open-eye arbors in the muscimol-treated cortex (MD-ND
and Norm in Muscimol 2w, Fig. 5 and Table 1) showed a much
more significant shrinkage than those observed in the BoNT/E-
treated cortex. The more significant shrinkage in previous
muscimol experiments should reflect the longer cortical inactiva-
tion rather than a difference in pharmacological effects of BoNT/
E and muscimol, because muscimol treatment for 1 week induced
the same level of shrinkage as BoNT/E treatment (MD-ND in
Muscimol 1w, Fig. 5 and Table 1, unpublished observation). On
the other hand, the arbors in the BoNT/E-treated cortex of BD
animals were similar to the arbors serving the deprived eye in the
muscimol-treated MD animals, although they were shorter than
those in muscimol-BD animals (MD-D and BD in Muscimol 2w,
Fig. 5 and Table 1). Therefore, experience-dependent axon
retraction can occur in the absence of synaptic transmission when
cortical activity is suppressed.
Figure 2. Effects of BoNT/E on cortical activity and Egr-1 expression level in visual cortex. (A) Examples of spike activity in rat visual
cortex contralateral (upper trace, Control) and ipsilateral (lower trace, BoNT/E) to BoNT/E injection site recorded 1 week after injection. BoNT/E
blocked neuronal activity only in the injected cortex. (B) Egr-1 expression level is significantly decreased in the BoNT/E injected cortex. The upper
right panel shows examples of immunoblots for Egr-1 in the visual cortex of normal rats (Norm) and that 1 week after BoNT/E injection. Blot densities
were normalized to those of GAPDH and expressed as the ratio to those of Egr-1 in normal animals. Error bars indicate SEM. *: P,0.05 (n=5 each,
unpaired t-test).
doi:10.1371/journal.pone.0004193.g002
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In this study, the geniculocortical axons in the visual cortex
inactivated by BoNT/E treatment showed a highly significant
shrinkage and the shrinkage could be alleviated by visual
deprivation (Figs. 4 and 5, Table 1), as observed previously in
the muscimol-treated cortex [9,10]. These results indicate that the
axon retraction in the inactivated cortex can proceed in the
absence of synaptic transmission.
BoNT/E is a metalloprotease that selectively cleaves the synaptic
protein SNAP-25 and prevents transmitter release [12,13]. Because
administration ofBoNT/Ecan block synapticactivityreversibly, itis
used as a tool to address the role of synaptic activity in vivo [14,15].
We found no spontaneous or visually evoked activity in the BoNT/
E-treated region of the visual cortex even 1 week after the
administration. Consistent with previous reports [14,15], we did
not find a sign of general deleterious effect of BoNT/E on the
cortical tissue. The activity blockade was well confined to the vicinity
of the injection sites, which extended up to 10 mm in the anterior-
posterior direction, and we observed vigorous visual responses
outside the area and in the contralateral visual cortex. In addition,
we detected small activities in the middle cortical depth, possibly
representing afferent activity, as similarly observed in the muscimol-
treated cortex [9,10,18], indicating that BoNT/E did not disturb the
electric activity of afferent axons. The Nissl-stained sections of the
BoNT/E-treated cortex showed no differences in neuronal density
and cortical thickness from those of the normal cortex. Finally, if
BoNT/E had exerted a deleterious effect on afferent axons, such
effect should have caused a degradation of presynaptic afferents for
both eyes. The present finding that the retraction of afferents in the
BoNT/E-treated cortex depends on their own activity argues
strongly against this possibility.
Previous results in the muscimol-treated cortex suggest that
presynaptic activity in the absence of postsynaptic activity leads to
the retraction of afferent axons, on the basis of the assumption that
muscimol selectively suppresses the activity of postsynaptic cells
and does not have direct presynaptic effects. Pharmacological
studies showed that muscimol binds selectively to GABAA
receptors, which are located only on postsynaptic sites [19,20].
However, it was also reported that muscimol at a high
concentration might act on GABAB receptors, which are located
on geniculocortical axon terminals [21]. This finding raises a
possibility that the retraction of open-eye axons observed in the
muscimol-treated cortex might be induced by activation of
presynaptic GABAB receptors rather than by cortical activity
blockade. The present finding that open-eye afferents retract in the
BoNT/E-treated cortex provides evidence against this possibility
because BoNT/E can inactivate the visual cortex without
activating GABAB receptors.
The afferent arbors in the BoNT/E-treated cortex of normal-
vision animals showed a significant retraction, because they were
smaller than those at the start of BoNT/E injection (arbors in the
normal P40 animals). The open-eye arbors in the cortex treated
with muscimol for 1 week showed a retraction extent comparable
to that in the BoNT/E-treated cortex (MD-ND in Muscimol 1w,
Fig. 5 and Table 1). Thus, it is reasonable to state that cortical
inhibition by BoNT/E induces the retraction of afferent axons to
the same extent as cortical inactivation by muscimol. On the other
hand, visual deprivation prevented afferent arbors from retracting
in the BoNT/E-treated cortex, as found previously in the
muscimol-treated cortex [10]. However, the deprived-eye arbors
in the BoNT/E-treated cortex were much shorter in total length
and had fewer branch points than the arbors in the normal
animals at the time of perfusion (P50, Fig. 5 and Table 1),
suggesting that cortical inactivation prevented an axonal elonga-
tion during normal development. Furthermore, the deprived-eye
arbors in the BoNT/E-treated cortex were shorter in length than
the arbors in the normal animals at the time of BoNT/E injection
Figure 3. Example of labeled axons in BoNT/E-treated visual cortex. (A) Low-magnification image of coronal section across visual cortex of
BoNT/E-injected kitten. An arrowhead indicates the BoNT/E injection site. (B, C) High-magnification view of two regions in A far from (dotted line, B)
and close to (solid line, C) the injection site. Egr-1 signal is detectable in the area far from the injection site (B), whereas the signal is very low in the
area near the injection site (C). The staining at the lower-left in C represents labeled axons. (D) Enlarged view of geniculocortical axons in BoNT/E
inactivated area (box in C). Scale bar, A: 1 mm, B, C: 100 mm, D:1 0mm.
doi:10.1371/journal.pone.0004193.g003
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BoNT/E-treated cortex might not be completely rescued from
retraction and become smaller than the normal arbors, although
the extent of retraction is much smaller than that of the open-eye
arbors in the inactivated cortex.
The previous findings in the muscimol-treated cortex suggest a
mechanism of axon retraction depending on the activity of
presynaptic afferents. Only active afferents might express struc-
tural changes in response to a repulsive signal, which may be a
repulsive substance or a depletion of trophic substances in the
inactivated cortex, for example. It is also possible, however, that
the signal for retraction might be delivered only to active afferents
as a result of local synaptic interaction with cortical neurons,
because muscimol treatment does not prevent synaptic transmis-
sion itself. The present results obtained in the BoNT/E-treated
cortex, in which synaptic transmission was prevented, strongly
argue against the latter possibility and support presynaptic
mechanisms of open-eye axon retraction. The activity of axons
Figure 4. Examples of reconstructed arbors of normal-vision animals (A) and BD animals (B). Arrowheads on the right side of each arbor
in frontal view indicate the borders between cortical layers. The arbors in frontal view are aligned on the border between layers IV and V. Surface view
images were calculated on a computer by rotating frontal-view arbors 90u along the axis indicated by the dotted lines. Only portions above the layer
IV and V border are shown as surface view images. The arbors in the inactivated visual cortex of normal-vision animals (A) appear to be smaller than
those of BD animals (B). D, dorsal; V, ventral; M, medial; L, lateral; A, anterior; P, posterior. Scale bar, 400 mm.
doi:10.1371/journal.pone.0004193.g004
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changes. Active afferents might have greater Ca
2+ influx at their
terminals than deprived-eye afferents. The difference in Ca
2+
concentration might regulate axon behavior, as demonstrated in
the guidance of growth cones [22]. Alternatively, presynaptic
activity might regulate the response of axons to a repulsive signal
in the cortex. For example, recent experiments demonstrated that
p75 neurotrophin receptors mediate axon retraction during
Figure 5. Quantitative analysis of arbor morphology. Scattergrams show a plot of two measures, total length (A) and number of branch
points (B), for all arbors in this study together with the measures obtained under various experimental conditions published previously [9,10,17].
Total length (A) is calculated by adding the lengths of all axon segments constituting the terminal field of an arbor. The number of branch points (B)
indicates the total number of axonal bifurcations. Only portions above the layer IV and V border are considered for these analyses. Each symbol
represents the data of an arbor, and short horizontal lines indicate the means of individual groups. Red and blue symbols represent open-eye and
deprived-eye arbors, respectively. The data obtained in the BoNT/E- and muscimol-treated cortex are indicated by the shaded and striped areas,
respectively. The duration of cortical treatment is indicated at the top. Arbor and animal groups are indicated at the bottom as follows: Norm, arbors
of animals with normal vision; BD, arbors of binocularly deprived animals; ND and D of MD, nondeprived-eye and deprived-eye arbors of monocularly
deprived animals; P30, P40 and P50, arbors of normal animals on postnatal days 30, 40 and 50.
doi:10.1371/journal.pone.0004193.g005
Table 1. Statistical comparison of geniculocortical arbors.
Cortical treatment BoNT/E Muscimol (1w) Muscimol (2w) None
Arbor Groups
BD
(P48–50)
MD-ND
(P47–53)
MD-ND
(P42–43)
MD-D
(P41–45)
Norm
(P40–46)
BD
(P40–46) P30 P40 P50
Total length
BoNT/E-norm 0.001 Q ns 0.001 q 0.034Q ns 0.001Q 0.002Q 0.001 Q 0.002 Q
BoNT/E-BD - ns 0.0001 q ns 0.0001 q ns ns 0.004 Q 0.003 Q
Number of branch points
BoNT/E-norm 0.027 Q ns 0.002 q 0.041Q 0.003 q 0.001Q ns 0.003 Q 0.002 Q
BoNT/E-BD - ns 0.0001 q ns ,0.0001 q 0.021Q ns ns 0.003Q
Statistical comparisons among arbor groups are provided as p values (Wilcoxon rank sum test). ns, not significant (p.0.05). Arrows for the p values indicate whether
each of the two measures of the BoNT/E-norm and BoNT/E-BD groups shown on the left is larger (q) or smaller (Q) than those of the arbor groups shown on the top.
Arbor and animal groups: norm and BD, arbors of normal-vision and BD animals, respectively. MD-ND and MD-D, nondeprived-eye and deprived-eye arbors of MD
animals, respectively. The ages of the animals in each group at perfusion are given in parentheses below each experimental condition.
doi:10.1371/journal.pone.0004193.t001
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interest to note that p75 was observed to be regulated in an
activity-dependent manner in a study using neuronal cultures [25].
It is possible that such an activity-dependent regulation of
repulsive interactions underlie the experience-driven axon retrac-
tion in the visual system.
Although such hypothetical presynaptic mechanism of axon
retraction should operate also in the normal (active) cortex, the
afferent axons serving the open eye of MD animals and those
serving either eye in the normal-vision animals without muscimol
infusion had much longer length and more branching than those
in the inactivated cortex. When the cortex is active, cortical
neurons may release some substance to rescue the axonal
retraction or stabilize afferent synapses from the retraction. For
example, neurotrophic factors are known to be released from
target neurons and promote axonal growth [26,27]. Especially,
previous studies demonstrated that brain-derived neurotrophic
factor (BDNF) influence the cortical projection of LGN axons
(ocular dominance columns) [28,29] and its expression is regulated
in activity-dependent manner [30]. Therefore, two modes of
plasticity which allow weakening and strengthening of particular
pathways might operate concertedly in the developing visual
cortex.
In conclusion, the present findings provide anatomical evidence
that the experience-driven axon retraction in the inactivated visual
cortex can proceed in the absence of synaptic transmission. These
results suggest that presynaptic mechanisms play an important role
in the experience-dependent rearrangement of LGN axons.
Materials and Methods
All kittens (n=8) in this study were born in the breeding colony
of the Tottori University Research Center for Bioscience and
Technology. All Long-Evans rats (n=19) in this study were
obtained from Shimizu Laboratory Animal Supply Co. Ltd
(Kyoto, Japan). The experimental procedures used met the
regulation of the animal care committee of the Tottori University.
Surgery
A 30 G stainless steel cannula connected to a 10 ml Hamilton
syringe with a polyethylene tubing was inserted into the left
hemisphere of area 17 of the visual cortex in 6-week-old kittens
(postnatal days (P) 41–43). BoNT/E solution (100 nM in
phosphate-buffered saline (PBS, pH 7.4) containing 2% rat serum
albumin) was injected stereotaxically at three locations
(A=22.0 mm, L=1.0 mm; A=24.0 mm, L=1.0 mm;
A=26.0 mm, L=1.0 mm) at a depth of 2 mm from the cortical
surface (2 ml at each location; rate, 0.2 ml/min).
To label geniculocortical axons, we injected an anterograde
tracer, biotinylated dextran amine (BDA, MW 10 kDa, Molecular
Probe). A glass microelectrode filled with BDA solution (10% in
0.5 M NaCl) was positioned stereotaxically at LGN, which is
ipsilateral to the BoNT/E injection sites, with verification of depth
by monitoring visual responses. We used the pipettes with fine tips
(5–10 mm diameter) to minimize tissue damage that might label
the fiber of passage. BDA was injected iontophoretically (pipette
positive current of 5 mA, 2 s ON/2 s OFF pulses, 60–70 times) at
three to four sites in lamina A of LGN. A group of kittens (n=3)
was deprived of vision in both eyes by eyelid suture. All surgical
procedures were performed under sterile condition under
anesthesia with 2–3% isoflurane in N2O and O2 (1:1). All the
incisions were infiltrated with local anesthetics. The animals were
administered an antimicrobial agent (enrofloxacin, 5 mg/kg) every
day after the surgery until euthanasia.
Histology
After a survival period of one week, the cortical region inactivated
by BoNT/E was delineated physiologically by mapping cortical cell
activity with a tungsten microelectrode placed at various distances
from the sites of BoNT/E injection. The kittens were anesthetized
with pentobarbital(Nembutal, DainipponSumitomoPharma; initial
dose, 30 mg/kg; maintenance dose, 2–4 mg/kg/hr) during record-
ing experiments. When no spike activity except for injury discharges
was recorded while the electrode was advanced to a depth of
2000 mm, we determined the site to be inactivated by BoNT/E. A
27 G needle was inserted to form marks at the border of the
inactivated region. Then the animals were euthanized with an
overdose of pentobarbital (100 mg/kg, i.v.) and perfused transcar-
dially with cold PBS, followed by 4% paraformaldehyde in 0.1 M
phosphate buffer (PB, pH 7.4). The brain was removed and
postfixed in the fixative containing 20% sucrose. Tissue blocks
containing LGN and the entire caudal pole of the cortex were cut on
a freezing microtome in the frontal plane (50 mmt h i c k n e s s ) .A l l
sections were collected in PBS and processed for the standard ABC
method. Briefly, the sections were incubated overnight at 4uCi na
blocking solution containing 5% bovine serum albumin (BSA), 3%
normal goat serum (NGS) and 0.7% Triton X-100 in PBS. They
were then transferred to a solution containing the avidin-horseradish
peroxidase complex (Vector Laboratories, Burlingame, CA, USA),
0.1% Triton X-100 and 0.1% BSA in PBS and incubated overnight
at 4uC. After washing in PBS and Tris-buffer (50 mM, pH 7.4), they
were reacted with a solution containing 0.1% diaminobenzidine
hydrochloride, 0.025% nickel ammonium sulfate, 0.025% cobalt
chloride and 0.025% hydrogen peroxidase in Tris-buffer.
Selected sections containing the visual cortex were processed for
immunohistochemical staining of Egr-1. The sections were
incubated with the blocking solution overnight at 4uC. They were
then transferred to a solution of 2.5% BSA and 5% NGS in PBS
containing an Egr-1 antibody at a dilution of 1:10000 (rabbit
polyclonal antibody; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and incubated overnight at 4uC. After washing in PBS and
blocking, they were transferred to a solution containing 5% BSA,
2% NGS and 0.3% Triton X-100 in PBS containing a biotinylated
secondary antibody (biotinylated goat anti-rabbit IgG; Vector
Burlingame, CA, USA) and incubated for 1 hr at room tempera-
ture. After washing in PBS, they were transferred to a solution
containing avidin-horseradish peroxidase and incubated overnight
at 4uC. After washing in PBS and Tris-buffer, they were reacted
with a solution containing 0.01% diaminobenzidine hydrochloride,
0.025% nickel ammonium sulfate, 0.025% cobalt chloride and
0.035% hydrogen peroxidase in Tris-buffer. All sections were
mounted on MAS-coated slides, dehydrated in a graded series of
ethyl alcohol, cleared in xylene, and coverslipped. Selected sections
containing LGN or the visual cortex were stained with cresyl violet
for localization of layer boundaries and injection sites.
Axonal arbor analysis
All of the injection sites were well confined to a single lamina of
LGN. When an injection site invades the other lamina
representing the other eye, we eliminated all samples in the same
animal from arbor reconstruction. We analyzed the axonal arbors
in the area inactivated by BoNT/E defined physiologically. In
addition, our analysis is limited to axons with well-filled arbors that
could be followed up to their thinnest terminals. BDA-filled arbors
were reconstructed at 61000 magnification from serial sections in
3D with the aid of a computer graphic system (Neurolucida,
Microbrightfield, VT). We evaluated the size and complexity of
each arbor by measuring the total length of the arbor and the
number of branch points, respectively. The total length of each
Retraction of Active Axons
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constituting the terminal field of an arbor. Only the portion of the
arbor located in layers II/III and IV was considered for these
analyses. Very short endings less than 5 mm were omitted from the
analyses.
Western blotting
The adequate condition of BoNT/E injection was determined
using rats. BoNT/E solution (50 nM in PBS containing 2% rat
serum albumin) was injected at single location in area 17 of the
visual cortex (A=6.5 mm, L=4.0 mm from bregma; depth from
cortical surface, 0.8 mm) in 6-week-old rats using a 30 G stainless
steel cannula (1.5 ml; rate, 0.05 ml/min). On various days after
surgery, we recorded visual cortical activity with a tungsten
microelectrode under anesthesia induced with pentobarbital
(50 mg/kg, i.p.) After recording, the rats were euthanized with
an overdose of pentobarbital (150 mg/kg, i.p.) and cortical tissue
specimens including the visual cortex (A=6.5–7.5 mm, L=3.8–
4.4 mm from bregma) were dissected out. The tissue specimens
were homogenized with a glass-Teflon homogenizer and sonicated
in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholic
acid, 0.1% SDS, 1 mM EGTA, 1 mM EDTA, 2 mM tetrasodium
pyrophosphate, 4 mM para-nitrophenyl-phosphate, 1 mM sodi-
um orthovanadate, 5 mg/mL aprotinin and 1 mM PMSF in
50 mM Tris-HCl, pH 7.4). The homogenates were centrifuged at
700 g for 10 min at 4uC. The resultant pellets were dissolved in the
homogenizing buffer and stored at 280uC until western blotting
was performed. Protein concentration was determined with a
Micro BCA Protein Assay kit (Pierce, Rockford, IL, USA).
Proteins in the samples were separated by 12% or 7.5% sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE),
and transferred to a polyvinylidene difluoride membrane. The
membranes were blocked with 5% skimmilk in Tris-buffered saline
(TBS) containing Tween-20 (T-TBS) and incubated with T-TBS
containing a primary antibody against SNAP-25 (1:2000; mouse
monoclonal antibody; Covance, Princeton, NJ, USA), Egr-1
(1:2000) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH; 1:5000, mouse monoclonal antibody; Chemicon
Temecula, CA, USA) overnight at 4uC. They were then incubated
with a peroxidase-conjugated secondary antibody (1:5000, anti-
mouse IgG antibody, 1:5000, anti-rabbit IgG antibody, 1:10000,
anti-mouse IgG antibody; GE Healthcare, Piscataway, NJ, USA)
at room temperature for 1 hr. Signals were detected by enhanced
chemiluminescence (ECL kit; GE Healthcare) and quantified
using the ImageJ software (NIH, Bethesda, MD, USA). The blot
densities of the proteins of interest were normalized to those of
GAPDH in the same membrane.
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